A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma
Clinical trial NCT03802071 · COMPLETED
Trial details
- NCT number
- NCT03802071
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2022-08-10
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.